Bora Pharmaceutical Laboratories, a division of Bora Pharmaceuticals, has added roller compaction technology to its solid dose capability offerings at its Zhunan, Taiwan contract manufacturing and packaging facility. The Zhunan facility is a leader in the manufacture of complex oral solid dose (OSD) formulations with expertise in the use of solvents, Wurster Coating, or Extrusion-Spheronization....
Bora Pharmaceuticals Co., Ltd announced today that the contract development and manufacturing organization (CDMO) has successfully completed the acquisition of GSK’s Mississauga, Ontario (Canada) facility. Initially announced in March 2020, the site represents Bora Pharmaceuticals’ first manufacturing facility in North America and will become home to its North American headquarters. Establishing...
Bora Pharmaceuticals, a full-service contract development and manufacturing organisation (CDMO) which specialises in immediate and modified release tablets and capsules, along with serialised packaging, announced that its Chairman and CEO, Bobby Sheng, was unveiled as ‘CEO of the Year’ at the CPhI Pharma Awards 2020. The CEO of the Year award is granted to the C-suite executive who is able to...
The right outsourcing partner should open up access to expertise and technical capabilities in a broad range of dosage forms to ensure commercial success.August 1, 2020Volume 2020 Supplement, Issue 3Page Number: s6-s9By Felicity Thomas, Pharmaceutical Technology As the need for innovation in drug development is increasing, so too is the requirement for companies to partner with a contract...